Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for Chronic Central Serous Chorioretinopathy
NCT02153125Phase 2Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Apr 2014
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of eplerenone in Central Serous Chorioretinopathy (CSCR), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
eplerenone
03
Conditions
Central Serous Chorioretinopathy (CSCR)
Beyond the preview
Go deeper on NCT02153125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153125.